Antianginal And Anti-Ischemic Agents, Non-Hemodynamic

Non-hemodynamic antianginal and anti-ischemic agents are cardiovascular medications that alleviate myocardial ischemia and angina pectoris without producing clinically significant changes in heart rate, systemic blood pressure, or vascular tone They are primarily indicated for the management of chronic coronary syndromes and stable coronary artery disease, serving as useful monotherapy or add-on therapy, particularly in patients limited by hypotension or bradycardia

Non-hemodynamic antianginal and anti-ischemic agents are cardiovascular medications that alleviate myocardial ischemia and angina pectoris without producing clinically significant changes in heart rate, systemic blood pressure, or vascular tone

Unlike conventional hemodynamic therapies such as beta-blockers, calcium channel blockers, and nitrates, these agents exert their cardioprotective actions via cellular or metabolic pathways, most notably through the selective inhibition of the late inward sodium current—which reduces intracellular calcium overload and myocardial wall tension—or via myocardial metabolic modulation

Unlike conventional hemodynamic therapies such as beta-blockers, calcium channel blockers, and nitrates, these agents exert their cardioprotective actions via cellular or metabolic pathways, most notably through the selective inhibition of the late inward sodium current—which reduces intracellular calcium overload and myocardial wall tension—or via myocardial metabolic modulation

Unlike conventional hemodynamic therapies such as beta-blockers, calcium channel blockers, and nitrates, these agents exert their cardioprotective actions via cellular or metabolic pathways, most notably through the selective inhibition of the late inward sodium current—which reduces intracellular calcium overload and myocardial wall tension—or via myocardial metabolic modulation